Results

Sorrento Therapeutics Inc.

01/21/2022 | Press release | Distributed by Public on 01/21/2022 08:29

Sorrento Therapeutics, Inc. Corporate Presentation Regarding Sorrento Potent Omicron Neutralizing Antibody (nAb) STI-9167 IV and STI-9199 IN - Form 8-K